Clinical Trial Update: Ketamine Frequency Treatment for Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating a ketamine frequency treatment for major depressive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Essentia Health | Conditions: Treatment Resistant Depression | Phase 4 | Status: WITHDRAWN